BDRLQ.US Blonder Tongue Laboratories, Inc.
- Market cap
- USD 2.89K
- P/E
- -
- P/B
- 3.56x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2025.
Is BDRLQ.US undervalued?
Graham numberThe Graham number of Blonder Tongue Laboratories, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Blonder Tongue Laboratories, Inc. fundamental analysis
No fundamental analysis for Blonder Tongue Laboratories, Inc. yet.
Blonder Tongue Laboratories, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Blonder Tongue Laboratories, Inc.
Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers NXG modular IP video systems, CV transcoders, CV encoders, Aircaster off-air series, and the DRAKE series. The company also provides video encoding and transcoding, analog modulators, receivers and modulators, data over cable service interface specificat…
Full company profileBlonder Tongue Laboratories, Inc. financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
Blonder Tongue Laboratories, Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 20.9M | 22.5M | 23.3M | 21.7M | 19.8M | 16.4M | 15.8M | 18.1M | 13.2M | 11.2M | 11.7M |
| Gross Profit | 4.16M | 8.36M | 8.94M | 8.42M | 3.43M | 3.02M | 5.86M | 5.46M | 3.98M | 3.71M | 4.03M |
| Operating Income | -6.40M | -671K | 463K | -854K | -7.64M | -7.11M | -2.96M | -2.13M | -1.26M | -682K | -436K |
| EBITDA | -5.09M | 218K | 963K | -333K | 643K | -6.01M | 1.75M | -1.24M | -411K | 447K | 496K |
| Net Income | -6.77M | -1.20M | -384K | -1.34M | -742K | -7.47M | 84.0K | -2.92M | -2.12M | -1.25M | -1.26M |
| EPS | -1.05 | -0.16 | -0.05 | -0.15 | -0.08 | -0.76 | 0.01 | -0.22 | -0.15 | -0.09 | -0.09 |
| Balance Sheet | |||||||||||
| Total Assets | 16.2M | 15.0M | 15.2M | 15.6M | 18.3M | 11.1M | 11.9M | 15.0M | 11.3M | 9.43M | 9.27M |
| Total Liabilities | 8.86M | 8.47M | 7.76M | 8.43M | 11.0M | 9.89M | 8.63M | 13.9M | 11.9M | 11.2M | 11.3M |
| Shareholders' Equity | 7.37M | 6.53M | 7.41M | 7.17M | 7.36M | 1.24M | 3.29M | 1.07M | -524K | -1.73M | -2.04M |
| Cash & Short-term Investments | 9.00K | 468K | 168K | 559K | 572K | 69.0K | 274K | 79.0K | 8.00K | 33.0K | 93.0K |
| Total Debt | 6.38M | 6.06M | 6.45M | 5.85M | 9.42M | 9.89M | 7.95M | 15.5M | 9.27M | 8.14M | 8.17M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -798K | 771K | -237K | 587K | -6.54M | -3.21M | -1.17M | -1.38M | 1.99M | 1.04M | 708K |
| Capital Expenditure | 641K | 56.0K | 200K | 101K | 316K | 191K | 86.0K | 55.0K | 647K | 4.00K | 328K |
| Free Cash Flow | -1.44M | 715K | -437K | 486K | -6.85M | -3.40M | -1.25M | -1.44M | 1.34M | 1.04M | 380K |
| Ratios | |||||||||||
| ROE | -91.9% | -18.3% | -5.2% | -18.7% | -10.1% | -604.2% | 2.6% | -271.9% | - | - | - |
| ROA | -41.7% | -8.0% | -2.5% | -8.6% | -4.0% | -67.2% | 0.7% | -19.5% | -18.7% | -13.2% | -13.5% |
| Net Profit Margin | -32.3% | -5.3% | -1.6% | -6.2% | -3.7% | -45.6% | 0.5% | -16.1% | -16.0% | -11.2% | -10.8% |
| Debt to Equity | 0.87x | 0.93x | 0.87x | 0.82x | 1.28x | 8.00x | 2.42x | 14.40x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Blonder Tongue Laboratories, Inc. dividends
Blonder Tongue Laboratories, Inc. has not paid dividends in the last 9 fiscal years.
Who owns Blonder Tongue Laboratories, Inc.
- Insiders 29.97%
- Institutions 0.00%
- Public & others 70.03%
- Shares outstanding 14.5M
- Free float 5.29M
Blonder Tongue Laboratories, Inc. company profile
- Company name
- Blonder Tongue Laboratories, Inc.
- Ticker
- BDRLQ.US
- Exchange
- USA Stocks
- Sector
- Technology
- Industry
- Communication Equipment
- Employees
- 67
- Fiscal year end
- December
- Address
- One Jake Brown Road, Old Bridge, NJ, United States, 08857
- Phone
- 732 679 4000
- Website
- blondertongue.com
About Blonder Tongue Laboratories, Inc.
Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers NXG modular IP video systems, CV transcoders, CV encoders, Aircaster off-air series, and the DRAKE series. The company also provides video encoding and transcoding, analog modulators, receivers and modulators, data over cable service interface specification-cable modem termination systems, fiber optics, broadband amplifiers, test and measurement products, passives, and accessories. In addition, it provides end-of-life CableCARD solutions, secure reliable transport solutions, and local content solutions for hospitality networks. Blonder Tongue Laboratories, Inc. was founded in 1950 and is based in Old Bridge, New Jersey.
Blonder Tongue Laboratories, Inc. management
1- Mr. Don YoungPresident & CEO